Safe Empiric Antibiotics for Pregnant Women with Pneumonia

Risk Stratification and Antibiotic Selection

For low severity community-acquired pneumonia in pregnant women, the American College of Obstetricians and Gynecologists recommends amoxicillin 500 mg-1g PO q8h or amoxicillin-clavulanate 1-2g PO q12h as first-line therapy 1
For suspected atypical pathogens in low severity community-acquired pneumonia, azithromycin 500 mg PO daily for 3-5 days is recommended 1
For moderate severity community-acquired pneumonia in pregnant women, amoxicillin-clavulanate 1.2g IV q8h or ampicillin-sulbactam 1.5-3g IV q6h is recommended 1
For severe pneumonia or hospital-acquired pneumonia in pregnant women, the Infectious Diseases Society of America recommends piperacillin-tazobactam 4.5g IV q6h 2
For MRSA risk factors in severe pneumonia or hospital-acquired pneumonia, adding vancomycin or linezolid is recommended, but only if benefits outweigh risks 2
For aspiration pneumonia in pregnant women, clindamycin can be used if beta-lactams and macrolides are contraindicated 5

Clinical response should be monitored by simple clinical criteria, including temperature, respiratory, and hemodynamic parameters, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 5
C-reactive protein should be measured on days 1 and 3-4, especially in those with unfavorable clinical parameters, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 5
Treatment duration is typically 5-7 days for mild to moderate pneumonia, as recommended by the American College of Chest Physicians 1
Longer treatment (10-14 days) may be necessary for severe pneumonia or slow clinical response, as recommended by the Infectious Diseases Society of America 2